Patent · US Active

S-nitrosoglutathione reductase inhibitors

US9707212B2 · kind B2 · utility

0Cited by
6References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 2015
Grant dateJul 18, 2017
Priority date
Expiry dateOct 27, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.